Free Cash Flow Chart

View Free Cash Flow for ARGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 1.090B
December 31, 2025 734.26M
June 30, 2025 447.35M
December 31, 2024 -39.32M
June 30, 2024 -211.22M
December 31, 2023 -371.93M
June 30, 2023 -723.42M
December 31, 2022 -955.16M
June 30, 2022 -868.07M
December 31, 2021 -723.73M
June 30, 2021 -598.85M
Date Value
December 31, 2020 -398.65M
June 30, 2020 -255.80M
December 31, 2019 109.07M
June 30, 2019 189.72M
December 31, 2018 -61.16M
June 30, 2018 -58.03M
December 31, 2017 -42.95M
June 30, 2017 -30.70M
December 31, 2016 10.76M
June 30, 2016 15.00M
December 31, 2015 -15.51M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Autolus Therapeutics Plc -240.12M
Akari Therapeutics Plc -10.74M
Forte Biosciences, Inc. -72.03M
Evaxion AS --
DBV Technologies SA -152.18M

Free Cash Flow Related Metrics